Establishment Labs Holdings (ESTA) Net Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 2,770.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,770.00 |
| Dec 31, 2025 | 7,353.00 |
| Sep 30, 2025 | 2,075.00 |
| Jun 30, 2025 | 660.00 |
| Mar 31, 2025 | -646.00 |
| Dec 31, 2024 | -1,248.00 |
| Sep 30, 2024 | 3,455.00 |
| Jun 30, 2024 | -446.00 |
| Mar 31, 2024 | -1,792.00 |
| Dec 31, 2023 | -3,413.00 |
| Sep 30, 2023 | -2,737.00 |
| Jun 30, 2023 | 5,560.00 |
| Mar 31, 2023 | -1,024.00 |
| Dec 31, 2022 | 923.00 |
| Sep 30, 2022 | 189.00 |
| Jun 30, 2022 | -7,345.00 |
| Mar 31, 2022 | 747.00 |
| Dec 31, 2021 | -1,923.00 |
| Sep 30, 2021 | -3,189.00 |
| Jun 30, 2021 | 8,335.00 |
| Mar 31, 2021 | 4,961.00 |
| Dec 31, 2020 | 195.00 |
| Sep 30, 2020 | 3,725.00 |
| Jun 30, 2020 | -5,829.00 |
| Mar 31, 2020 | -2,064.00 |
| Dec 31, 2019 | 4,121.00 |
| Sep 30, 2019 | -6,392.00 |
| Jun 30, 2019 | -259.00 |
| Mar 31, 2019 | -780.00 |
| Dec 31, 2018 | -373.00 |
| Sep 30, 2018 | 15,376.00 |
| Jun 30, 2018 | 10,105.00 |